Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 356

1.

Mycobacterium ulcerans Population Genomics To Inform on the Spread of Buruli Ulcer across Central Africa.

Vandelannoote K, Phanzu DM, Kibadi K, Eddyani M, Meehan CJ, Jordaens K, Leirs H, Portaels F, Stinear TP, Harris SR, de Jong BC.

mSphere. 2019 Feb 6;4(1). pii: e00472-18. doi: 10.1128/mSphere.00472-18.

2.

Improving clinical and epidemiological predictors of Buruli ulcer.

Ayelo GA, Sopoh GE, Houezo JG, Fiodessihoue R, Affolabi D, Dossou AD, Barogui YT, Wadagni AAC, Agossadou DC, Hasker E, Portaels F, de Jong BC, Eddyani M.

PLoS Negl Trop Dis. 2018 Aug 6;12(8):e0006713. doi: 10.1371/journal.pntd.0006713. eCollection 2018 Aug.

3.

Subcutaneous Granulomatous Inflammation due to Basidiobolomycosis: Case Reports of 3 Patients in Buruli Ulcer Endemic Areas in Benin.

Brun LVC, Roux JJ, Sopoh GE, Aguiar J, Eddyani M, Meyers WM, Stubbe D, Akele Akpo MT, Portaels F, de Jong BC.

Case Rep Pathol. 2018 Jan 10;2018:1351694. doi: 10.1155/2018/1351694. eCollection 2018.

4.

Diagnostic Accuracy of Clinical and Microbiological Signs in Patients With Skin Lesions Resembling Buruli Ulcer in an Endemic Region.

Eddyani M, Sopoh GE, Ayelo G, Brun LVC, Roux JJ, Barogui Y, Affolabi D, Faber WR, Boelaert M, Van Rie A, Portaels F, de Jong BC.

Clin Infect Dis. 2018 Aug 31;67(6):827-834. doi: 10.1093/cid/ciy197.

5.

Bacterial diversity in Buruli ulcer skin lesions: Challenges in the clinical microbiome analysis of a skin disease.

Van Leuvenhaege C, Vandelannoote K, Affolabi D, Portaels F, Sopoh G, de Jong BC, Eddyani M, Meehan CJ.

PLoS One. 2017 Jul 27;12(7):e0181994. doi: 10.1371/journal.pone.0181994. eCollection 2017.

6.

Characterization of Mycobacterium chelonae-Like Strains by Comparative Genomics.

Nogueira CL, de Almeida LGP, Menendez MC, Garcia MJ, Digiampietri LA, Chimara E, Cnockaert M, Palomino JC, Portaels F, Martin A, Vandamme P, Leão SC.

Front Microbiol. 2017 May 8;8:789. doi: 10.3389/fmicb.2017.00789. eCollection 2017.

7.

Multiple Introductions and Recent Spread of the Emerging Human Pathogen Mycobacterium ulcerans across Africa.

Vandelannoote K, Meehan CJ, Eddyani M, Affolabi D, Phanzu DM, Eyangoh S, Jordaens K, Portaels F, Mangas K, Seemann T, Marsollier L, Marion E, Chauty A, Landier J, Fontanet A, Leirs H, Stinear TP, de Jong BC.

Genome Biol Evol. 2017 Mar 1;9(3):414-426. doi: 10.1093/gbe/evx003.

8.

Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance.

Zignol M, Dean AS, Falzon D, van Gemert W, Wright A, van Deun A, Portaels F, Laszlo A, Espinal MA, Pablos-Méndez A, Bloom A, Aziz MA, Weyer K, Jaramillo E, Nunn P, Floyd K, Raviglione MC.

N Engl J Med. 2016 Sep 15;375(11):1081-9. doi: 10.1056/NEJMsr1512438. No abstract available.

9.

[Stab wounds of the hand and forearm due to Kuluna in Kinshasa (Democratic Republic of Congo): types of injuries and treatment].

Kibadi K, Portaels F, Pichot Y, Kapinga M, Moutet F.

Rev Med Brux. 2015 Nov-Dec;36(6):468-74. French.

PMID:
26837110
10.

A Genomic Approach to Resolving Relapse versus Reinfection among Four Cases of Buruli Ulcer.

Eddyani M, Vandelannoote K, Meehan CJ, Bhuju S, Porter JL, Aguiar J, Seemann T, Jarek M, Singh M, Portaels F, Stinear TP, de Jong BC.

PLoS Negl Trop Dis. 2015 Nov 30;9(11):e0004158. doi: 10.1371/journal.pntd.0004158. eCollection 2015 Nov.

11.

Beninese Medicinal Plants as a Source of Antimycobacterial Agents: Bioguided Fractionation and In Vitro Activity of Alkaloids Isolated from Holarrhena floribunda Used in Traditional Treatment of Buruli Ulcer.

Yemoa A, Gbenou J, Affolabi D, Moudachirou M, Bigot A, Anagonou S, Portaels F, Martin A, Quetin-Leclercq J.

Biomed Res Int. 2015;2015:835767. doi: 10.1155/2015/835767. Epub 2015 May 28.

12.

Leprosy and Buruli ulcer: similarities suggest combining control and prevention of disability strategies in countries endemic for both diseases.

Walsh DS, De Jong BC, Meyers WM, Portaels F.

Lepr Rev. 2015 Mar;86(1):1-5. No abstract available.

PMID:
26065143
13.

Correction: Whole Genome Comparisons Suggest Random Distribution of Mycobacterium ulcerans Genotypes in a Buruli Ulcer Endemic Region of Ghana.

Ablordey AS, Vandelannoote K, Frimpong IA, Ahortor EK, Amissah NA, Eddyani M, Durnez L, Portaels F, de Jong BC, Leirs H, Porter JL, Mangas KM, Lam MM, Buultjens A, Seemann T, Tobias NJ, Stinear TP.

PLoS Negl Trop Dis. 2015 May 13;9(5):e0003798. doi: 10.1371/journal.pntd.0003798. eCollection 2015 May. No abstract available.

14.

Whole genome comparisons suggest random distribution of Mycobacterium ulcerans genotypes in a Buruli ulcer endemic region of Ghana.

Ablordey AS, Vandelannoote K, Frimpong IA, Ahortor EK, Amissah NA, Eddyani M, Durnez L, Portaels F, de Jong BC, Leirs H, Porter JL, Mangas KM, Lam MM, Buultjens A, Seemann T, Tobias NJ, Stinear TP.

PLoS Negl Trop Dis. 2015 Mar 31;9(3):e0003681. doi: 10.1371/journal.pntd.0003681. eCollection 2015 Mar. Erratum in: PLoS Negl Trop Dis. 2015 May;9(5):e0003798.

15.

Buruli ulcer in traveler from Suriname, South America, to the Netherlands.

Faber WR, de Jong B, de Vries HJ, Zeegelaar JE, Portaels F.

Emerg Infect Dis. 2015 Mar;21(3):497-9. doi: 10.3201/eid2103.141237.

16.

[Buruli ulcer in the health districts of the Democratic Republic of Congo from 1950 to 2013: literature review and new distribution map].

Kibadi K, Tiendrebeogo A, Ekoue Kinvi B, De Jong B, Boelaert M, Portaels F.

Med Sante Trop. 2014 Oct-Dec;24(4):420-9. doi: 10.1684/mst.2014.0385. Review. French.

17.

Investigating the role of free-living amoebae as a reservoir for Mycobacterium ulcerans.

Amissah NA, Gryseels S, Tobias NJ, Ravadgar B, Suzuki M, Vandelannoote K, Durnez L, Leirs H, Stinear TP, Portaels F, Ablordey A, Eddyani M.

PLoS Negl Trop Dis. 2014 Sep 4;8(9):e3148. doi: 10.1371/journal.pntd.0003148. eCollection 2014 Sep.

18.

Multicenter external quality assessment program for PCR detection of Mycobacterium ulcerans in clinical and environmental specimens.

Eddyani M, Lavender C, de Rijk WB, Bomans P, Fyfe J, de Jong B, Portaels F.

PLoS One. 2014 Feb 21;9(2):e89407. doi: 10.1371/journal.pone.0089407. eCollection 2014.

19.

[Mycobacterium ulcerans disease (Buruli ulcer) in Gabon: 2005-2011].

Bayonne Manou LS, Portaels F, Eddyani M, Book AU, Vandelannoote K, de Jong BC.

Med Sante Trop. 2013 Oct-Dec;23(4):450-7. doi: 10.1684/mst.2013.0259. French.

20.

Burden of Mycobacterium ulcerans disease (Buruli ulcer) and the underreporting ratio in the territory of Songololo, Democratic Republic of Congo.

Mavinga Phanzu D, Suykerbuyk P, Saunderson P, Ngwala Lukanu P, Masamba Minuku JB, Imposo DB, Mbadu Diengidi B, Kayinua M, Tamfum Muyembe JJ, Tshindele Lutumba P, de Jong BC, Portaels F, Boelaert M.

PLoS Negl Trop Dis. 2013 Dec 5;7(12):e2563. doi: 10.1371/journal.pntd.0002563. eCollection 2013.

21.

Insertion sequence element single nucleotide polymorphism typing provides insights into the population structure and evolution of Mycobacterium ulcerans across Africa.

Vandelannoote K, Jordaens K, Bomans P, Leirs H, Durnez L, Affolabi D, Sopoh G, Aguiar J, Phanzu DM, Kibadi K, Eyangoh S, Manou LB, Phillips RO, Adjei O, Ablordey A, Rigouts L, Portaels F, Eddyani M, de Jong BC.

Appl Environ Microbiol. 2014 Feb;80(3):1197-209. doi: 10.1128/AEM.02774-13. Epub 2013 Dec 2.

22.

Genetic diversity and population structure of Mycobacterium marinum: new insights into host and environmental specificities.

Broutin V, Bañuls AL, Aubry A, Keck N, Choisy M, Bernardet JF, Michel C, Raymond JC, Libert C, Barnaud A, Stragier P, Portaels F, Terru D, Belon C, Dereure O, Gutierrez C, Boschiroli ML, Van De Perre P, Cambau E, Godreuil S.

J Clin Microbiol. 2012 Nov;50(11):3627-34. doi: 10.1128/JCM.01274-12. Epub 2012 Sep 5.

23.

Amoebae as potential environmental hosts for Mycobacterium ulcerans and other mycobacteria, but doubtful actors in Buruli ulcer epidemiology.

Gryseels S, Amissah D, Durnez L, Vandelannoote K, Leirs H, De Jonckheere J, Silva MT, Portaels F, Ablordey A, Eddyani M.

PLoS Negl Trop Dis. 2012;6(8):e1764. doi: 10.1371/journal.pntd.0001764. Epub 2012 Aug 7.

24.

On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer.

Doig KD, Holt KE, Fyfe JA, Lavender CJ, Eddyani M, Portaels F, Yeboah-Manu D, Pluschke G, Seemann T, Stinear TP.

BMC Genomics. 2012 Jun 19;13:258. doi: 10.1186/1471-2164-13-258.

25.

A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project.

Merle CS, Sismanidis C, Sow OB, Gninafon M, Horton J, Lapujade O, Lo MB, Mitchinson DA, Perronne C, Portaels F, Odhiambo J, Olliaro P, Rustomjee R, Lienhardt C, Fielding K.

Trials. 2012 May 18;13:61. doi: 10.1186/1745-6215-13-61.

26.

Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.

Fraga AG, Martins TG, Torrado E, Huygen K, Portaels F, Silva MT, Castro AG, Pedrosa J.

PLoS One. 2012;7(3):e33406. doi: 10.1371/journal.pone.0033406. Epub 2012 Mar 8.

27.

Effects of decontamination, DNA extraction, and amplification procedures on the molecular diagnosis of Mycobacterium ulcerans disease (Buruli ulcer).

Affolabi D, Sanoussi N, Vandelannoote K, Odoun M, Faïhun F, Sopoh G, Anagonou S, Portaels F, Eddyani M.

J Clin Microbiol. 2012 Apr;50(4):1195-8. doi: 10.1128/JCM.05592-11. Epub 2012 Jan 18.

28.

hsp65 PCR-restriction analysis (PRA) with capillary electrophoresis for species identification and differentiation of Mycobacterium kansasii and Mycobacterium chelonae-Mycobacterium abscessus group.

Sajduda A, Martin A, Portaels F, Palomino JC.

Int J Infect Dis. 2012 Mar;16(3):e193-7. doi: 10.1016/j.ijid.2011.11.011. Epub 2012 Jan 11.

29.

The TDR Tuberculosis Strain Bank: a resource for basic science, tool development and diagnostic services.

Vincent V, Rigouts L, Nduwamahoro E, Holmes B, Cunningham J, Guillerm M, Nathanson CM, Moussy F, De Jong B, Portaels F, Ramsay A.

Int J Tuberc Lung Dis. 2012 Jan;16(1):24-31. doi: 10.5588/ijtld.11.0223.

PMID:
22236841
30.

Effect of a control project on clinical profiles and outcomes in buruli ulcer: a before/after study in Bas-Congo, Democratic Republic of Congo.

Phanzu DM, Suykerbuyk P, Imposo DB, Lukanu PN, Minuku JB, Lehman LF, Saunderson P, de Jong BC, Lutumba PT, Portaels F, Boelaert M.

PLoS Negl Trop Dis. 2011 Dec;5(12):e1402. doi: 10.1371/journal.pntd.0001402. Epub 2011 Dec 27.

31.

Mycobacterium ulcerans infection (Buruli ulcer) on the face: a comparative analysis of 13 clinically suspected cases from the Democratic Republic of Congo.

Phanzu DM, Mahema RL, Suykerbuyk P, Imposo DH, Lehman LF, Nduwamahoro E, Meyers WM, Boelaert M, Portaels F.

Am J Trop Med Hyg. 2011 Dec;85(6):1100-5. doi: 10.4269/ajtmh.2011.10-0530.

32.

Situation of bovine tuberculosis in Ecuador.

Proaño-Pérez F, Benítez-Ortiz W, Portaels F, Rigouts L, Linden A.

Rev Panam Salud Publica. 2011 Sep;30(3):279-86.

PMID:
22069076
33.

Mycobacteria in terrestrial small mammals on cattle farms in Tanzania.

Durnez L, Katakweba A, Sadiki H, Katholi CR, Kazwala RR, Machang'u RR, Portaels F, Leirs H.

Vet Med Int. 2011;2011:495074. doi: 10.4061/2011/495074. Epub 2011 Jun 8.

34.

Post-mortem examination and laboratory-based analysis for the diagnosis of bovine tuberculosis among dairy cattle in Ecuador.

Proaño-Pérez F, Benitez-Ortiz W, Desmecht D, Coral M, Ortiz J, Ron L, Portaels F, Rigouts L, Linden A.

Prev Vet Med. 2011 Aug 1;101(1-2):65-72. doi: 10.1016/j.prevetmed.2011.04.018. Epub 2011 Jun 8.

35.

European 1: a globally important clonal complex of Mycobacterium bovis.

Smith NH, Berg S, Dale J, Allen A, Rodriguez S, Romero B, Matos F, Ghebremichael S, Karoui C, Donati C, Machado Ada C, Mucavele C, Kazwala RR, Hilty M, Cadmus S, Ngandolo BN, Habtamu M, Oloya J, Muller A, Milian-Suazo F, Andrievskaia O, Projahn M, Barandiarán S, Macías A, Müller B, Zanini MS, Ikuta CY, Rodriguez CA, Pinheiro SR, Figueroa A, Cho SN, Mosavari N, Chuang PC, Jou R, Zinsstag J, van Soolingen D, Costello E, Aseffa A, Proaño-Perez F, Portaels F, Rigouts L, Cataldi AA, Collins DM, Boschiroli ML, Hewinson RG, Ferreira Neto JS, Surujballi O, Tadyon K, Botelho A, Zárraga AM, Buller N, Skuce R, Michel A, Aranaz A, Gordon SV, Jeon BY, Källenius G, Niemann S, Boniotti MB, van Helden PD, Harris B, Zumárraga MJ, Kremer K.

Infect Genet Evol. 2011 Aug;11(6):1340-51. doi: 10.1016/j.meegid.2011.04.027. Epub 2011 May 6.

PMID:
21571099
36.

Buruli ulcer: a review of in vitro tests to screen natural products for activity against Mycobacterium ulcerans.

Yemoa A, Gbenou J, Affolabi D, Moudachirou M, Bigot A, Anagonou S, Portaels F, Quetin-Leclercq J, Martin A.

Planta Med. 2011 Apr;77(6):641-6. doi: 10.1055/s-0030-1250642. Epub 2011 Jan 14. Review.

PMID:
21240839
37.

Buruli ulcer prevalence and altitude, Benin.

Sopoh GE, Johnson RC, Anagonou SY, Barogui YT, Dossou AD, Houézo JG, Phanzu DM, Tente BH, Meyers WM, Portaels F.

Emerg Infect Dis. 2011 Jan;17(1):153-4. doi: 10.3201/eid1701.100644. No abstract available.

38.

African 2, a clonal complex of Mycobacterium bovis epidemiologically important in East Africa.

Berg S, Garcia-Pelayo MC, Müller B, Hailu E, Asiimwe B, Kremer K, Dale J, Boniotti MB, Rodriguez S, Hilty M, Rigouts L, Firdessa R, Machado A, Mucavele C, Ngandolo BN, Bruchfeld J, Boschiroli L, Müller A, Sahraoui N, Pacciarini M, Cadmus S, Joloba M, van Soolingen D, Michel AL, Djønne B, Aranaz A, Zinsstag J, van Helden P, Portaels F, Kazwala R, Källenius G, Hewinson RG, Aseffa A, Gordon SV, Smith NH.

J Bacteriol. 2011 Feb;193(3):670-8. doi: 10.1128/JB.00750-10. Epub 2010 Nov 19. Erratum in: J Bacteriol. 2012 Mar;194(6):1641.

39.

Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.

Walsh DS, Portaels F, Meyers WM.

Dermatol Clin. 2011 Jan;29(1):1-8. doi: 10.1016/j.det.2010.09.006. Review.

PMID:
21095521
40.

Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.

Fraga AG, Cruz A, Martins TG, Torrado E, Saraiva M, Pereira DR, Meyers WM, Portaels F, Silva MT, Castro AG, Pedrosa J.

Infect Immun. 2011 Jan;79(1):421-30. doi: 10.1128/IAI.00820-10. Epub 2010 Oct 25.

41.

Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms.

Sopoh GE, Dossou AD, Brun LV, Barogui YT, Houézo JG, Affolabi D, Anagonou SY, Johnson RC, Kestens L, Portaels F.

Am J Trop Med Hyg. 2010 Aug;83(2):307-13. doi: 10.4269/ajtmh.2010.09-0617.

42.

Family relationship, water contact and occurrence of Buruli ulcer in Benin.

Sopoh GE, Barogui YT, Johnson RC, Dossou AD, Makoutodé M, Anagonou SY, Kestens L, Portaels F.

PLoS Negl Trop Dis. 2010 Jul 13;4(7):e746. doi: 10.1371/journal.pntd.0000746.

43.

Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).

Kibadi K, Boelaert M, Fraga AG, Kayinua M, Longatto-Filho A, Minuku JB, Mputu-Yamba JB, Muyembe-Tamfum JJ, Pedrosa J, Roux JJ, Meyers WM, Portaels F.

PLoS Negl Trop Dis. 2010 Jul 6;4(7):e736. doi: 10.1371/journal.pntd.0000736.

44.

Recent advances in leprosy and Buruli ulcer (Mycobacterium ulcerans infection).

Walsh DS, Portaels F, Meyers WM.

Curr Opin Infect Dis. 2010 Oct;23(5):445-55. doi: 10.1097/QCO.0b013e32833c2209. Review.

PMID:
20581668
45.

Diversity of Mycobacterium tuberculosis genotypes circulating in Ndola, Zambia.

Mulenga C, Shamputa IC, Mwakazanga D, Kapata N, Portaels F, Rigouts L.

BMC Infect Dis. 2010 Jun 17;10:177. doi: 10.1186/1471-2334-10-177.

46.

Terrestrial small mammals as reservoirs of Mycobacterium ulcerans in benin.

Durnez L, Suykerbuyk P, Nicolas V, Barrière P, Verheyen E, Johnson CR, Leirs H, Portaels F.

Appl Environ Microbiol. 2010 Jul;76(13):4574-7. doi: 10.1128/AEM.00199-10. Epub 2010 Apr 30.

47.

Fitness of Mycobacterium tuberculosis strains of the W-Beijing and Non-W-Beijing genotype.

von Groll A, Martin A, Stehr M, Singh M, Portaels F, da Silva PE, Palomino JC.

PLoS One. 2010 Apr 16;5(4):e10191. doi: 10.1371/journal.pone.0010191.

48.

Growth kinetics of Mycobacterium tuberculosis measured by quantitative resazurin reduction assay: a tool for fitness studies.

von Groll A, Martin A, Portaels F, da Silva PE, Palomino JC.

Braz J Microbiol. 2010 Apr;41(2):300-3. doi: 10.1590/S1517-83822010000200006. Epub 2010 Jun 1.

49.

Buruli ulcer, Central African Republic.

Minime-Lingoupou F, Beyam N, Zandanga G, Manirakiza A, N'Domackrah A, Njuimo S, Eyangoh S, Cottin J, Marsollier L, Marion E, Portaels F, Le Faou A, Bercion R.

Emerg Infect Dis. 2010 Apr;16(4):746-8. doi: 10.3201/eid1604.090195. No abstract available.

50.

Buruli ulcer lesions in HIV-positive patient.

Kibadi K, Colebunders R, Muyembe-Tamfum JJ, Meyers WM, Portaels F.

Emerg Infect Dis. 2010 Apr;16(4):738-9. doi: 10.3201/eid1604.091343. No abstract available.

Supplemental Content

Loading ...
Support Center